NCT01311713 · Interventional trial
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Solid Tumors
Delaware Valley sites
- Teva Investigational Site 2 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory